Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXALIPLATIN vs OXCARBAZEPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OXALIPLATIN vs OXCARBAZEPINE: Safety Overview

Metric OXALIPLATIN OXCARBAZEPINE
Total FAERS Reports 56,406 10,809
Deaths Reported 6,501 864
Death Rate 11.5% 8.0%
Hospitalizations 21,980 3,159
Average Patient Age 61.5 yrs 37.1 yrs
% Female Patients 42.1% 54.9%
FDA Approval Date Apr 28, 2011 Apr 30, 2025
Manufacturer Camber Pharmaceuticals, Inc. Bryant Ranch Prepack
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription